title: [Pharmacology of fibrates].
abstract: Fibrates are drugs commonly used in hypertriglyceridemias. After their absorption, fibrates are metabolized by the liver, using P450 isoenzymes not shared by statins. However, for some fibrates, such as genfibrozil, an interaction with statins can occur during their liver glucuronidation, or by displacement of free fraction of statins linked to proteins in plasma. Plasma half-life is variable among fibrates (2-80 h). Recently it has been shown that fibrates produce plasma lipid changes mainly by stimulating peroxisome-proliferation activation receptors alpha. Through this action, there is an increase in the transcription of some genes related to lipid metabolism, such as LLP, APOAI, APOAII, ABCA-1, as well as decrease in the expression of APOCIII, and many other actions.
authors.affiliation: Divisão de Moléstias Cardiovasculares, Faculdade de Ciências Médicas de Santos, UNILUS.
authors.forename: Hermes Toros
authors.initials: HT
authors.lastname: Xavier
mesh_terms: D000924:Anticholesteremic Agents / Q000378:metabolism / Q000494:pharmacology*; D002994:Clofibrate / Q000378:metabolism / Q000494:pharmacology*; D006801:Humans; D050356:Lipid Metabolism / Q000187:drug effects
chemical_list: D000924:Anticholesteremic Agents; D002994:Clofibrate